Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for angiotensin root_notes_note in Note (approximate match)

Showing 141 - 150 of 165 results

First page
Previous page
15
Next page
Next page

OPADRY II Y-22-7719 WHITE

B38S8YKT74

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II 85F18422 WHITE

UM45RMS9QT

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II 85F18378 WHITE

VTB5DCJ7N6

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II 33G11938 GREEN

B53ZH89YAO

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II 32K580000 WHITE

OQ25C9K54Z

Status:

Possibly Marketed Outside US

Source:

ANDA078329

(2024)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b19b8c34-e0c1-4982-92fc-34dbe7384935

First approved in 2024

Source:

ANDA078329

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b19b8c34-e0c1-4982-92fc-34dbe7384935

Class:

G1 SPECIFIED SUBSTANCE

(1,2-CYCLOHEXANEDIAMINE-N,N') DIIODIDOPLATINUM(II), (SP-4-2-(1R-TRANS))-

A6IL7532PP

Search for Structure

Status:

Investigational

Source:

NCT02266745: Phase 2 Interventional Active, not recruiting Advanced Solid Tumors

(2014)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02266745

Class (Stereo):

CHEMICAL (ABSOLUTE)

KT-II-115 hydrochloride

87H2YTA3KM

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

ALTERNATIVE DEFINITION for [ANGIOTENSIN III]

XH7F04LXTF

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

ALTERNATIVE DEFINITION for [ANGIOTENSIN I]

9C880YQG7C

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

IPROCINODINE II HYDROCHLORIDE

41L7L7LGVL

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

B38S8YKT74
Not a public record

Concept

OPADRY II Y-22-7719 WHITE

UM45RMS9QT
Not a public record

Concept

OPADRY II 85F18422 WHITE

VTB5DCJ7N6
Not a public record

Concept

OPADRY II 85F18378 WHITE

Concept

OPADRY II 33G11938 GREEN

OQ25C9K54Z
Not a public record

Concept

OPADRY II 32K580000 WHITE

Structure of (1,2-CYCLOHEXANEDIAMINE-N,N') DIIODIDOPLATINUM(II), (SP-4-2-(1R-TRANS))-

ABSOLUTE

(1,2-CYCLOHEXANEDIAMINE-N,N') DIIODIDOPLATINUM(II), (SP-4-2-(1R-TRANS))-

Structure of KT-II-115 hydrochloride

ABSOLUTE

KT-II-115 hydrochloride

Structure of ALTERNATIVE DEFINITION for [ANGIOTENSIN III]

ABSOLUTE

ALTERNATIVE DEFINITION for [ANGIOTENSIN III]

Structure of ALTERNATIVE DEFINITION for [ANGIOTENSIN I]

ABSOLUTE

ALTERNATIVE DEFINITION for [ANGIOTENSIN I]

Structure of IPROCINODINE II HYDROCHLORIDE

ABSOLUTE

IPROCINODINE II HYDROCHLORIDE

Showing 141 - 150 of 165 results

First page
Previous page
15
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1